Visual acuity distribution by time and dose
| Follow up, study group | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 3 weeks | 6 weeks | 12 weeks | 6 months | 12 months | |||||||
| Low (n = 18) | High (n = 16) | Low (n = 18) | High (n = 15) | Low (n = 17) | High (n = 13) | Low (n = 17) | High (n = 16) | Low (n = 17) | High (n = 11) | Low (n = 17) | High (n = 12) | |
| ⩾20/64 | 6 (33) | 0 (0) | 6 (33) | 1 (7) | 2 (12) | 1 (8) | 3 (18) | 0 (0) | 2 (12) | 1 (9) | 2 (12) | 1 (8) |
| 20/125 to 20/80 | 4 (22) | 9 (56) | 4 (22) | 7 (47) | 2 (12) | 5 (38) | 2 (12) | 8 (50) | 3 (18) | 2 (18) | 1 (6) | 1 (8) |
| 20/250 to 20/160 | 3 (17) | 1 (6) | 2 (11) | 2 (13) | 7 (41) | 1 (8) | 4 (24) | 2 (12) | 2 (12) | 2 (18) | 2 (12) | 1 (8) |
| ⩽20/320 | 5 (28) | 6 (38) | 6 (33) | 5 (33) | 6 (35) | 6 (46) | 8 (47) | 6 (38) | 10 (59) | 6 (55) | 12 (71) | 9 (75) |
| Median | 20/100 | 20/125 | 20/125 | 20/125 | 20/200 | 20/160 | 20/200 | 20/160 | 20/400 | 20/320 | 20/400 | 20/320 |
| p Value Wilcoxon | 0.19 | 0.69 | 0.95 | 0.41 | 0.62 | 0.67 | ||||||